Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 65 or older who have been diagnosed with locally advanced stomach cancer (stage II or stage III) and are preparing to have surgery to remove the cancer.
- People who are planned to receive chemotherapy after surgery, starting within 4 to 8 weeks of the operation, whether treated as an outpatient or staying in hospital.
- People who are expected to live for more than 3 months.
- People who are awake, alert, and able to communicate by speaking or writing, and who are willing to take part in procedures involved in the trial.
- People who have read the trial information and signed a consent form agreeing to participate.
Who may not be able to join:
- People who have difficulty thinking clearly or who, in the treating doctor's judgment, are unable to cooperate with the trial's procedures.
- People who are currently receiving other cancer treatments at the same time, such as radiation therapy or additional surgery.
- People who have more than one type of cancer that all require treatment at the same time.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparing surgical complications between frail and non-frail patients using the Clavien-Dindo grading system.; Utilize CTCAE v5.0 to assess the grade and frequency of adverse events and treatment-related toxicity in frail and non-frail patient groups, and compare the differences between the two.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.